| Primary |
| Cardiac Failure |
26.0% |
| Drug Use For Unknown Indication |
13.7% |
| Hypertension |
11.0% |
| Oedema |
8.2% |
| Chronic Obstructive Pulmonary Disease |
5.5% |
| Insomnia |
5.5% |
| Osteoporosis |
4.1% |
| Anxiety |
2.7% |
| Atrial Septal Defect |
2.7% |
| Dyslipidaemia |
2.7% |
| Gastritis |
2.7% |
| Product Used For Unknown Indication |
2.7% |
| Sciatica |
2.7% |
| Prophylaxis Of Nsaid Gastric Ulceration |
1.4% |
| Acute Myocardial Infarction |
1.4% |
| Blood Pressure Increased |
1.4% |
| Depression |
1.4% |
| Diabetes Mellitus |
1.4% |
| Gastric Ulcer |
1.4% |
| Hyperlipidaemia |
1.4% |
|
| Rhabdomyolysis |
17.6% |
| Hepatic Function Abnormal |
11.8% |
| Pseudoaldosteronism |
8.8% |
| Intracardiac Thrombus |
5.9% |
| Liver Disorder |
5.9% |
| Toxic Epidermal Necrolysis |
5.9% |
| Toxic Skin Eruption |
5.9% |
| Tubulointerstitial Nephritis |
5.9% |
| Vitamin B1 Deficiency |
5.9% |
| Aplasia Pure Red Cell |
2.9% |
| Hyperkalaemia |
2.9% |
| No Therapeutic Response |
2.9% |
| Penile Oedema |
2.9% |
| Pleural Effusion |
2.9% |
| Renal Failure Chronic |
2.9% |
| Sepsis |
2.9% |
| Somnolence |
2.9% |
| White Blood Cell Count Decreased |
2.9% |
|
| Secondary |
| Cardiac Failure |
23.1% |
| Hypertension |
22.3% |
| Angina Pectoris |
7.4% |
| Drug Use For Unknown Indication |
6.6% |
| Pulmonary Arterial Hypertension |
5.0% |
| Atrial Fibrillation |
3.7% |
| Chronic Hepatitis C |
3.7% |
| Prinzmetal Angina |
3.3% |
| Osteoporosis |
2.9% |
| Insomnia |
2.5% |
| Renal Failure Chronic |
2.5% |
| Type 2 Diabetes Mellitus |
2.5% |
| Cardiac Failure Congestive |
2.1% |
| Cardiac Valve Disease |
2.1% |
| Gastritis |
2.1% |
| Cardiac Failure Chronic |
1.7% |
| Dizziness |
1.7% |
| Oedema |
1.7% |
| Reflux Oesophagitis |
1.7% |
| Spinal Osteoarthritis |
1.7% |
|
| Urinary Tract Infection |
14.8% |
| Vomiting |
13.0% |
| Systemic Lupus Erythematosus |
11.1% |
| Rhabdomyolysis |
9.3% |
| Toxic Epidermal Necrolysis |
7.4% |
| Renal Impairment |
5.6% |
| Cardiac Failure |
3.7% |
| Interstitial Lung Disease |
3.7% |
| Intracardiac Thrombus |
3.7% |
| Renal Failure Chronic |
3.7% |
| Renal Tubular Disorder |
3.7% |
| White Blood Cell Count Decreased |
3.7% |
| White Blood Cell Count Increased |
3.7% |
| Cholecystitis |
1.9% |
| Drug Hypersensitivity |
1.9% |
| Hair Colour Changes |
1.9% |
| Hyperkalaemia |
1.9% |
| Hypertension |
1.9% |
| Inappropriate Antidiuretic Hormone Secretion |
1.9% |
| Pulmonary Haemorrhage |
1.9% |
|
| Concomitant |
| Hypertension |
15.4% |
| Prophylaxis |
11.6% |
| Cardiac Failure |
9.7% |
| Drug Use For Unknown Indication |
8.6% |
| Product Used For Unknown Indication |
7.8% |
| Pain |
5.2% |
| Diabetes Mellitus |
5.1% |
| Atrial Fibrillation |
4.0% |
| Cardiac Failure Chronic |
3.9% |
| Multiple Myeloma |
3.6% |
| Pulmonary Arterial Hypertension |
3.4% |
| Angina Pectoris |
3.0% |
| Infection Prophylaxis |
3.0% |
| Hyperlipidaemia |
2.9% |
| Type 2 Diabetes Mellitus |
2.9% |
| Asthma |
2.5% |
| Insomnia |
1.9% |
| Metastatic Renal Cell Carcinoma |
1.9% |
| Polyuria |
1.9% |
| Gastritis |
1.8% |
|
| Pneumonia |
9.4% |
| Hepatic Function Abnormal |
7.1% |
| Renal Impairment |
7.1% |
| White Blood Cell Count Decreased |
6.5% |
| Renal Disorder |
5.9% |
| Vomiting |
5.9% |
| Death |
5.3% |
| Pyrexia |
5.3% |
| Sudden Death |
4.7% |
| Cardiac Failure |
4.1% |
| Interstitial Lung Disease |
4.1% |
| Pleural Effusion |
4.1% |
| Renal Failure |
4.1% |
| Stevens-johnson Syndrome |
4.1% |
| Tumour Lysis Syndrome |
4.1% |
| White Blood Cell Count Increased |
4.1% |
| Prinzmetal Angina |
3.5% |
| Renal Failure Acute |
3.5% |
| Rhabdomyolysis |
3.5% |
| Septic Shock |
3.5% |
|
| Interacting |
| Hypertension |
75.0% |
| Dementia Alzheimer's Type |
25.0% |
|
|
